Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B ‐cell lymphoma

The Journal of Pathology,Volume 0, Issue ja, -Not available-.

Source: The Journal of Pathology - June 7, 2018 Category: Pathology Authors: Zebing Liu , Ying Cai , Yu Yang , Anqi Li , Rui Bi , Lisha Wang , Xiaohan Shen , Weige Wang , Yijun Jia , Baohua Yu , Bing Cao , Wenli Cui , Ping Wei , Xiaoyan Zhou Source Type: research